Related Experiment Video
Updated: Mar 27, 2026

09:29
Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog
Published on: October 13, 2023
2.4K
Retinal Cell Degeneration in Animal Models
Masayuki Niwa1, Hitomi Aoki2, Akihiro Hirata3
1Medical Science Division, United Graduate School of Drug Discovery and Medical Information Sciences, Gifu 501-1194, Japan. mniwa@gifu-u.ac.jp.
International Journal of Molecular Sciences
|January 20, 2016
Summary
This review compares animal models of retinal cell degeneration, including chemical, autoimmune, mechanical, and ischemic types. These models help understand disease mechanisms and develop new treatments for retinal damage.
Area of Science:
- Ophthalmology
- Neuroscience
- Toxicology
Background:
- Retinal cell degeneration underlies various vision-impairing diseases.
- Understanding disease mechanisms is crucial for developing effective therapies.
- Animal models are essential tools for studying retinal pathologies.
Purpose of the Study:
- To provide a comprehensive overview of diverse animal models for retinal cell degeneration.
- To comparatively analyze target regions, pathology, and mechanisms of different models.
- To highlight the utility of these models in advancing therapeutic strategies.
Main Methods:
- Review of existing literature on chemically induced models (N-methyl-D-aspartate, CoCl2).
- Analysis of autoimmune models (experimental autoimmune encephalomyelitis).
- Examination of mechanically induced models (optic nerve crush, light-induced).
- Inclusion of ischemic models (transient retinal ischemia).
Main Results:
- Detailed description of various retinal cell degeneration models.
- Comparative analysis of induced pathologies and underlying mechanisms.
- Identification of specific target regions affected in each model.
Conclusions:
- Animal models offer valuable insights into retinal degeneration.
- Comparative analysis aids in selecting appropriate models for research.
- These models are pivotal for the development of novel therapeutic drugs for retinal damage.

